FDA Set to Authorize Pfizer COVID-19 Booster Shot in Adolescents
The FDA is poised to authorize a third booster dose of the Pfizer-BioNTech COVID-19 vaccine for use in adolescents aged 12 to 15.
Source: Drug Industry Daily
The FDA is poised to authorize a third booster dose of the Pfizer-BioNTech COVID-19 vaccine for use in adolescents aged 12 to 15.
Source: Drug Industry Daily